A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
New research reveals that men who skip prostate cancer screenings face a staggering 45% higher risk of death from the disease. Learn why regular check-ups are crucial for your health and survival.
